Page 5

Dingdang gets $220m funding delivery
The SoftBank and Sinopharm-backed medicine delivery service will allocate the funding to diversifying its business, potentially adding teleconsultation, counselling and insurance.
One Medical eyes $2.1bn Iora acquisition
Humana and Cox Enterprises are set to exit the primary care provider in an all-share acquisition by publicly listed peer One Medical.
Tata Digital works out $75m for CureFit
Tata subsidiary Tata Digital Digital has hired CureFit’s CEO as part of a $75m investment round for the Unilever Ventures-backed health and fitness app developer.
Helix rings up $50m series C
Mayo Clinic returned to reinvest in the genomics platform developer three years after backing its series B round alongside Illumina.
Daily Deal Round Up: June 7, 2021
SoftBank is set to exit smart scheduling software developer as its Vision Fund 2 invests in artificial intelligence technology unicorn AInnovation.
Babylon agrees $4.2bn reverse merger
Munich Re and Centene-backed digital health software provider Babylon Health is set to get a public listing through the deal.
CVRx looks to pump $75m out of IPO
The Johnson & Johnson, GlaxoSmithKline and DaVita HealthCare Partners-backed medical device producer is looking to raise $75m in an offering on the Nasdaq Global Market.
Iksuda seals $47m in funding
IP Group sold a $5m stake to biopharmaceutical company Celltrion as part of a series A round for oncology therapy developer Iksuda.
CapitalG appoints three vice-presidents
Nina Gerson, Jamie Rosen and Jeremy Zhu have all stepped up after conducting a number of deals on behalf of Alphabet's growth equity subsidiary.
Citi Impact Fund reaches five more
Citi has now invested in Greenwood, MoCaFi, Moving Analytics, OhmConnect and Sweeten through its $200m Impact Fund.

test reg


Not yet subscribed?

See your subscription offers here